Intellipharmaceutics International Inc. (IPCI)

[doogdilinger]

There's zero need of any NAZ de-listing talk...they have until next march to regain compliance and even then they can still file for extensions.

And no matter how any of us even remotely attempt to slice or dice the FocalinXR and SeroquelXR numbers...we're on track for IPCI to book an absolute MINIMUM $25M in fiscal 2018 revenues on just those 2 drugs...without taking into account any changes whatsoever to potential IPCI catalysts.

Nobody in their right mind is gonna value IPCI at a sub $35M market cap when they're booking a minimum +$25M revs all next year...so the only thing worth focusing on for now is what plans new CFO Patience has in store to begin rebuilding/restoring investor/market confidence in this stock.

The worst of the post Rexista adcom storm is over IMO and with this weeks investor perception assessment taking place...clearly new CFO Patience is serious about coming up with solutions to overcome the post Rexista adcom storm glta